Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Human Study Evaluating the Effects of Beta Glucan 500 on Markers of Biological Age and Immune Age: An Open-label Pilot Study

NCT07104929 is registered in ClinicalTrials.gov with OvationLab as lead sponsor.

NCT NCT07104929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07104929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Human Study Evaluating the Effects of Beta Glucan 500 on Markers of Biological Age and Immune Age: An Open-label Pilot Study
Lead sponsor
OvationLab
Phase
Phase 2
Overall status
Completed
Start date
May 14, 2025
Completion date
October 9, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging